Related Experiment Videos
Visual evoked potential characteristics and early diagnosis of Pelizaeus-Merzbacher disease
P Apkarian1, J C Koetsveld-Baart, P G Barth
1Department of Visual Systems Analysis, The Netherlands Ophthalmic Research Institute, Amsterdam.
Insights
Early diagnosis of Pelizaeus-Merzbacher disease is possible using visual evoked potentials (VEP). This electrophysiological test provides an objective measure to monitor disease progression in infants with this leukodystrophy.
Area of Science:
- Neuroscience
- Ophthalmology
- Genetics
Background:
- Pelizaeus-Merzbacher disease (PMD) is a rare, X-linked leukodystrophy impacting myelin development.
- Early diagnosis and monitoring are crucial for managing PMD, but objective biomarkers are limited.
Observation:
- This study evaluated the utility of visual evoked potentials (VEP) for diagnosing and tracking PMD in an infant.
- The patient underwent VEP testing at 11 and 58 weeks of age, alongside age-matched controls.
Findings:
- VEP testing revealed abnormal spatial and temporal vision, indicative of a myelination disorder.
- The electrophysiological results allowed for early diagnosis and confirmation of PMD.
- VEP provided an objective measure of disease progression over the follow-up period.
Implications:
- Pediatric electrodiagnosis using VEP offers reliable assessment of visual function and maturation in leukodystrophies like PMD.
- VEP can serve as a valuable tool for early detection and monitoring of neurological disorders affecting the visual pathways.
- This approach aids in understanding disease progression and evaluating potential interventions.
Objective:
Early diagnosis of Pelizaeus-Merzbacher disease; assessment of disease progression.
Design:
Pediatric neuro-ophthalmology evaluation of visual function with pattern and luminance visual evoked potentials; behavioral state assessment; electrophysiological diagnostic test; baseline estimates at the age of 11 weeks; 1-year follow-up.
Setting:
University hospital electrodiagnostic vision research laboratory.
Case Study:
X-linked Pelizaeus-Merzbacher disease; leukodystrophy; patient tested at the age of 11 weeks and at the age of 58 weeks for follow-up; five age-matched normal controls.
Interventions:
Physical therapy, medication, evaluation.
Main Outcome:
Early diagnosis; diagnostic confirmation; objective monitor of disease progression.
Results:
Abnormal spatial and temporal vision and abnormal visual pathway maturation; visual evoked potentials of proband with Pelizaeus-Merzbacher disease were grossly abnormal, reflecting myelination disorder.
Conclusions:
Visual evoked potential pediatric electrodiagnosis yields reliable measures of visual function and visual system maturation in leukodystrophy.